Neurocrine Biosciences, Inc.(NBIX)

Biopharmaceutical company focused on neurological and endocrine-related diseases

1 Insight

Investment Insights

AI-generated insights about Neurocrine Biosciences, Inc. from various financial sources

Monday, April 6, 2026

Neutral

Mentioned as the acquirer of Soleno Therapeutics.

Martin Shkreli
4/6/26 - sorry for the wait!
Martin ShkreliYouTube33 days ago